Guy Van Camp Selected Research

Dobutamine

9/2008	Head to head comparison of transesophageal and transthoracic contrast-enhanced echocardiography during dobutamine administration for the detection of coronary artery disease.
4/2002	Relationship between late potentials and myocardial viability assessed by dobutamine echocardiography in the early postinfarction period.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guy Van Camp Research Topics

Disease

29	Hearing Loss (Hearing Impairment) 08/2019 - 05/2002
27	Neoplasms (Cancer) 12/2023 - 09/2011
15	Otosclerosis 04/2022 - 04/2006
10	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 10/2015
10	Autosomal Dominant 5 Deafness 01/2018 - 07/2003
9	Heart Valve Diseases (Valvular Heart Disease) 10/2018 - 04/2004
7	Heart Failure 10/2023 - 12/2007
6	Breast Neoplasms (Breast Cancer) 02/2023 - 06/2012
6	Nonsyndromic Deafness 01/2016 - 08/2003
5	Adenocarcinoma 01/2022 - 01/2017
5	Aortic Valve Insufficiency (Aortic Regurgitation) 06/2009 - 09/2007
4	Atrial Fibrillation 11/2023 - 06/2008
4	Aortic Valve Stenosis (Aortic Stenosis) 01/2023 - 04/2016
4	Malignant Mesothelioma 01/2021 - 10/2016
4	Sensorineural Hearing Loss 01/2021 - 06/2005
4	Mitral Valve Insufficiency (Mitral Regurgitation) 10/2017 - 09/2007
4	Deafness (Deaf Mutism) 01/2011 - 01/2004
3	Carcinogenesis 01/2023 - 11/2019
3	Primitive Neuroectodermal Tumors (PNET) 01/2018 - 04/2015
3	Inflammation (Inflammations) 09/2016 - 01/2010
3	Noise-Induced Hearing Loss (Acoustic Trauma) 09/2012 - 08/2006
3	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 04/2009 - 09/2007
2	Carcinoma (Carcinomatosis) 01/2023 - 01/2021
2	Myocardial Infarction 01/2022 - 04/2002
2	Mesothelioma 01/2021 - 10/2018
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 09/2008
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019 - 01/2018
2	Autosomal Recessive Deafness 01/2017 - 07/2005
2	Triple Negative Breast Neoplasms 01/2014 - 01/2014
2	type 1 Stickler syndrome 07/2011 - 09/2006
2	Conductive Hearing Loss 09/2010 - 12/2009
2	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 08/2010 - 03/2010
1	Adenoma (Adenomas) 01/2023
1	Chronic recurrent multifocal osteomyelitis 10/2022
1	Rheumatic Diseases (Rheumatism) 10/2022
1	Stroke (Strokes) 01/2022
1	Common Cold 05/2021
1	Infections 05/2021
1	Severe Acute Respiratory Syndrome 05/2021

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2010
14	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2003
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2003
12	Capsules (Microcapsules)IBA 08/2019 - 09/2007
9	Connexin 26IBA 10/2018 - 04/2003
4	NucleotidesIBA 12/2023 - 01/2007
4	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2018
4	AsbestosIBA 01/2021 - 10/2016
4	Messenger RNA (mRNA)IBA 01/2017 - 01/2007
4	Pergolide (Permax)FDA Link 06/2009 - 04/2004
3	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2014
3	PotassiumIBA 09/2012 - 08/2006
2	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2023 - 01/2020
2	Panitumumab (Vectibix)FDA Link 01/2023 - 01/2018
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 11/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 10/2015
2	Complement System Proteins (Complement)IBA 01/2018 - 10/2004
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 11/2011
2	withaferin AIBA 01/2018 - 01/2014
2	Hormones (Hormone)IBA 01/2017 - 01/2014
2	Carrier Proteins (Binding Protein)IBA 01/2017 - 10/2012
2	Mutant Proteins (Protein, Mutant)IBA 01/2012 - 09/2011
2	FluoridesIBA 06/2010 - 12/2009
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 12/2009 - 09/2007
2	Serotonin (5 Hydroxytryptamine)IBA 09/2009 - 09/2007
2	Amino Acids FDA Link 03/2009 - 05/2002
2	Myosins (Myosin)IBA 01/2009 - 04/2004
2	Dobutamine FDA LinkGeneric 09/2008 - 04/2002
2	Transforming Growth Factor beta (TGF-beta)IBA 04/2008 - 09/2007
2	CollagenIBA 09/2006 - 04/2006
1	Trastuzumab (Herceptin)FDA Link 02/2023
1	AnthracyclinesIBA 02/2023
1	Bevacizumab (Avastin)FDA Link 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Unithiol (DMPS)IBA 01/2023
1	CrizotinibIBA 01/2023
1	entrectinibIBA 01/2023
1	CytokinesIBA 10/2022
1	Aggrecans (Aggrecan)IBA 04/2022
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2022
1	Chromogranin AIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 05/2021
1	InterferonsIBA 05/2021
1	PolyphenolsIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	SirtuinsIBA 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	mangiferinIBA 01/2021

Therapy/Procedure

15	Therapeutics 02/2023 - 05/2013
3	Patient Readmission 10/2023 - 11/2016
3	Conservative Treatment 01/2022 - 04/2016
2	Cardiac Resynchronization Therapy 01/2019 - 04/2011
2	Catheters 01/2018 - 12/2007
2	Drug Therapy (Chemotherapy) 08/2014 - 07/2010
2	Punctures 11/2008 - 06/2008
1	Electric Countershock (Cardioversion) 11/2023
1	Transcatheter Aortic Valve Replacement 01/2023
1	Immunomodulation 05/2021
1	Immunotherapy 01/2021